(which operates as Hims and Hers) Location: San Francisco, CaliforniaStore Websites: and Letter Date: September 9, 2025FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Types of Products Sold: Prescribes and sells compounded semaglutide, tirzepatide and other compounded productsType of Warning: Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetFDA Warning: The website makes false claims about compounded drug products, including: Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients. The claims imply that the products are the same as an FDA-approved product when they are not
Buyers should review the product identifier, supplier details, hazard information, handling instructions, storage conditions, transport considerations, exposure controls and disposal guidance
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Heise T., Mari A., DeVries J.H., Urva S., Li J., Pratt E.J., Coskun T., Thomas M.K., Mather K.J., Haupt A., et al